ALZN — Alzamend Neuro, Inc.

ALZNAlzamend Neuro, Inc.

NAS · US · Healthcare · Biotechnology · alzamend.com

1.150USD-0.87%Mkt Cap: 4.38M USDP/E: —Last update: 2026-06-01

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a the…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap4.38M USD

Enterprise Value1.81M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-4.51M USD

Revenue/Share—

Last Price1.150 USD

Fiscal Year EndApr 2025

MR QuarterJan 2026

Employees4

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.46

PEG—

EV/EBITDA-0.26

EV/Revenue—

P/S—

P/B2.07

EPS (TTM)-3.67

EPS (Forward)-2.60

52W Range

0.84007% of range5.200

52W High5.200 USD

52W Low0.8400 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-113.78%

ROA-98.09%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.57M USD

CapEx (TTM)300.00K USD

FCF Margin—

FCF Yield-82.65%

Net Debt-2.71M USD

Net Debt/EBITDA0.39

Balance Sheet

Debt/Equity—

Current Ratio1.99

Quick Ratio1.46

Book Value/Sh0.5740 USD

Cash/Share0.7130 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:9

Split DateMay 12, 2025

Analyst Consensus

Rating—

Target (Mean)25.00 USD

Target Range25.00 USD – 25.00 USD

# Analysts1

Ownership

Shares Out.3.80M

Float3.79M

Insiders0.53%

Institutions3.04%

Short Interest

Short Ratio4.1d

Short % Float5.28%

Short % Out.5.25%

Shares Short199.57K

Short (prev mo.)248.55K

Technical

SMA 501.163 (-1.1%)

SMA 2001.966 (-41.5%)

Beta0.11

S&P 52W Chg27.94%

Avg Vol (30d)58.12K

Avg Vol (10d)83.01K

Technical Indicators

RSI (14)53.7

MACD-0.0045

MACD Signal-0.0255

MACD Hist.+0.0210

BB Upper1.207 USD

BB Middle1.090 USD

BB Lower0.9732 USD

BB Width21.48%

ATR (14)0.0868 USD

Vol Ratio (20d)1.12x